Skip to Main Content

Six biotech companies went public over the course of three days this week, and three more are expected before the month is out. That puts biotech on a pace not seen since the frothy days of its most recent boom — a boom that was quickly followed by a painful correction that could repeat itself if biotech once more goes over its skis.

The week’s IPOs mark 29 for the year, and if all goes according to plan, biotech will see 31 companies go public before the first half of 2018 wraps up — more than in the entirety of 2012.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!